0001209191-23-049516.txt : 20230914
0001209191-23-049516.hdr.sgml : 20230914
20230914194101
ACCESSION NUMBER: 0001209191-23-049516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230912
FILED AS OF DATE: 20230914
DATE AS OF CHANGE: 20230914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YEAMAN KEVIN J
CENTRAL INDEX KEY: 0001200469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 231256280
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-12
0
0001308547
Dolby Laboratories, Inc.
DLB
0001200469
YEAMAN KEVIN J
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
1
1
0
0
President and CEO
0
Class A Common Stock
2023-09-12
4
M
0
18060
42.98
A
69939
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2023-09-12
4
S
0
16711
82.5645
D
53228
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2023-09-12
4
S
0
1349
83.3096
D
51879
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
119557
D
Employee Stock Option (Right to Buy)
42.98
2023-09-12
4
M
0
18060
0.00
D
2024-12-15
Class A Common Stock
18060
72486
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
The shares were sold in multiple transactions at prices ranging from $82.10 to $83.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $83.11 to $83.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares held following the reported transactions include 119,557 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2022 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.
/s/ Daniel Rodriguez, as Attorney-in-Fact for Kevin Yeaman
2023-09-14